#drugdevelopment search results
#drugdevelopment #patent #pharmacy #TopPrivateCollege #TopEngineeringCollege #RKGIT #rkgit #rkgitian #rkgitians #rkgitstudents #rkgitm #wearerkgit #PharmacyAdmissions2026
We’re at #GermanBiotechDays today 👋 Meet the hVIVO team at Booth F09 to discuss smarter, more connected approaches to early development and clinical delivery. 📍 Booth F09 📲 Book via the event partnering app or email [email protected] #Biotech #DrugDevelopment #HVO
#Drugdevelopment takes ~10 years, but most of the delay isn't science; it's manual work. AI regulatory tools reshape workflow. Are you ready? Full breakdown: tinyurl.com/58vnnjnv #RegulatoryAffairs #RegulatoryIntelligence #Pharma #AIinPharma #RegTech #AI #DDReg
Discover how strategic partnerships are transforming bioprocessing and biopharma R&D. Watch Dr. Manisha Desai of @bmsnews in our debut BioPharm Drug Digest episode: hubs.li/Q048FFqv0 #BiopharmaPartnerships #DrugDevelopment #BioPharmDrugDigest
At Biohaven, #DaysMatter. We’re dedicated to advancing science with the speed and rigor that patients expect and deserve. Explore our pipeline: bit.ly/4jOEmL8 #ClinicalResearch #DrugDevelopment
#QPS unites advanced technology and scientific expertise to drive efficient #drugdevelopment through our #biomarker and #translationalmedicine services. Learn more about QPS #bioanalysis by visiting shorturl.at/iAl4F or by emailing [email protected]. #genetherapy
Discover how to implement AI‑driven continuous API production with in‑line benchtop NMR and modular hardware to gain real‑time control, more resilient quality, and compact, scalable operations. Download the free whitepaper: goto.bruker.com/3PZksnd #Pharma #NMR #DrugDevelopment
Could this be a COPD breakthrough? @AstraZeneca’s LUNA program shows tozorakimab (IL-33 mAb) cuts exacerbations in Phase III trials. How will IL-33 blockade impact the industry pipeline? Learn more! hubs.li/Q048FmSB0 #COPD #DrugDevelopment #ClinicalTrials #Biopharma
The future of psychiatry may see SSRIs lose their dominance. As new drugs and marketing dollars emerge, expect the narrative to shift, highlighting SSRIs' limitations and risks. Get ready for a sober look at their true effectiveness. #Psychiatry #MentalHealth #DrugDevelopment
The Biosimulation Market is expected to grow 5X by 2035, reaching USD 25.1 billion 📊 🔍 Discover key trends & opportunities: 👉 gminsights.com/industry-analy… #BiotechIndustry #DrugDevelopment #Innovation #GlobalMarketInsights
Racura Oncology teams with Purdue Uni to advance cancer drug candidate. #ASX #Drugdevelopment $RAC @RacuraOncology buff.ly/gkFQNLs
Today, the International Scietific Advasory Bord gives positive recommendations to out OP JAK project NETPHARM. Thank to all participants and institutions. #CzechScience #DrugDevelopment
Dimerix to conduct blinded review of phase III kidney disease trial data #ASX #Drugdevelopment $DXB @dimerixltd buff.ly/L7793lP.
Besting Vertex Pharmaceuticals’ kidney disease asset wasn’t enough to impress Wall Street, which appears to be “getting hung up” with the broad population data in Maze Therapeutics’ trial, according to Mizuho. #drugdevelopment #pharma #biospace hubs.li/Q048mDFH0
In our latest interview, Giuseppe Elia, Site Director at Catalent’s Dartford facility, shares his expert insights on why micronization is essential in today’s pharmaceutical landscape. Read the interview: ow.ly/lT0v50YMSJl #Micronization #DrugDevelopment #CDMO
Neurotech opens first site for phase III autism trial #ASX #DrugDevelopment $NTI buff.ly/GoktBtN
#ESMOTAT26: In his interview in the #ESMODailyReporter, Timothy A. Yap, TAT Honorary Awardee, shares insights on innovative approaches to exploit synthetic lethality to ‘drug the undruggable’ 📌ow.ly/pUIq50YuA7u #DrugDevelopment
The scalability bottleneck ends here. 🛑 Join @Curi_Bio CEO Nicholas Geisse for an @Xtalks webinar 5/26 to unveil a new roadmap for regulatory-grade NAMs. Learn how to scale 3D human functional models for IND. 🧪 👉: hubs.ly/Q04cgmhf0 #Pharma #NAMs #DrugDevelopment
A pancreatic cancer drug could double survival and cut the risk of death by more than a third, a trial suggests. 🔗 Full story: buff.ly/s52Lx03 #PancreaticCancer #DrugDevelopment #CancerResearch #ClinicalTrial #Oncology
#Drugdevelopment takes ~10 years, but most of the delay isn't science; it's manual work. AI regulatory tools reshape workflow. Are you ready? Full breakdown: tinyurl.com/58vnnjnv #RegulatoryAffairs #RegulatoryIntelligence #Pharma #AIinPharma #RegTech #AI #DDReg
We’re at #GermanBiotechDays today 👋 Meet the hVIVO team at Booth F09 to discuss smarter, more connected approaches to early development and clinical delivery. 📍 Booth F09 📲 Book via the event partnering app or email [email protected] #Biotech #DrugDevelopment #HVO
#drugdevelopment #patent #pharmacy #TopPrivateCollege #TopEngineeringCollege #RKGIT #rkgit #rkgitian #rkgitians #rkgitstudents #rkgitm #wearerkgit #PharmacyAdmissions2026
pharmadevicenews.com/what-orion-cor… #Mesothelioma #Oncology #DrugDevelopment #ClinicalTrials #OrphanDrug #Biotech #CancerResearch #RareDiseases #FDA #PrecisionMedicine
pharmadevicenews.com
What Orion Corporation’s FDA orphan designation for ODM-212 means for mesothelioma treatment...
Discover how Orion Corporation’s ODM-212 orphan drug status could reshape mesothelioma treatment and drive innovation in Hippo pathway targeting.
In our latest interview, Giuseppe Elia, Site Director at Catalent’s Dartford facility, shares his expert insights on why micronization is essential in today’s pharmaceutical landscape. Read the interview: ow.ly/lT0v50YMSJl #Micronization #DrugDevelopment #CDMO
AI is a big theme at #AACR26, looking forward to co-chairing (w Dr. John Tainer) Minisymposium on #AI and #drugdevelopment #drugresistance #cancerstemness #metabolism #CTC Today 2:30-4:30 at room 28 (upper level) @AACR 7 presenters @UTMDAnderson @LurieCancer @NUFeinbergMed ...
We are thrilled to announce a new strategic partnership with @CellCarta! 🤝 Together, we are advancing proteomics solutions to accelerate #drugdevelopment & other targeted therapeutics. Press Release: hubs.la/Q04cLKy90 #ImmunoOncology #Leinco
AI technologies and tools are improving the speed and cost-efficiency for companies in drug development, augmenting manual workflows that have grown too costly and slow. Learn more in @PYMNTS here: buff.ly/ibUhoWI #AI #pharmaceutical #drugdevelopment
Report from Global Banking & Finance Review Boehringer Ingelheim unveils a £150M London AI centre to accelerate drug discovery and targeted medicines, signaling a bold global push in AI-driven pharma R&D. #AI #Pharma #DrugDevelopment #Biotech #London #Li… globalbankingandfinance.com/boehringer-ing…
#QPS unites advanced technology and scientific expertise to drive efficient #drugdevelopment through our #biomarker and #translationalmedicine services. Learn more about QPS #bioanalysis by visiting shorturl.at/iAl4F or by emailing [email protected]. #genetherapy
@LeincoSTL and @CellCarta collaborate to advance proteomics solutions and applications for drug development hubs.li/Q04cHB7p0 #Proteomics #DrugDevelopment #Biomarker #ClinicalResearch
From API R&D to commercial manufacturing—integrated, seamless, and built for speed. Discover how Aizant enables end-to-end drug development. youtube.com/watch?v=Ed9Czt… #CDMO #DrugDevelopment #Aizant #PharmaCDMO
youtube.com
YouTube
Aizant Drug Research Solutions Pvt Ltd
1 day to go. #CPHIJapan 2026 in Tokyo is almost here, and we are ready to engage in conversations that shape the next phase of #drugdevelopment. Meet Akash Shah from our team for collaboration, book your slot here - veedalifesciences.com/events-and-con… #VeedaLifesciences #GlobalCRO
New article: Regulation by Proximity. How claims of direct access can reshape perception, shift capital, and compete with evidence in biopharma. Full material is available via the link: evteevadvisory.com/perspectives/t… #Biopharma #DrugDevelopment #FDA #RegulatoryAffairs #HealthcarePolicy
Join us at the Global #DDFSummit from May 18-20 in Berlin! Don’t miss the chance to speak with our experts and learn how we help customers with #drugdevelopment challenges. Schedule a meeting hovione.com/contact-us #drugformulation #drugdelivery #spraydrying #solubility #cdmo
Alzheimer’s drug pioneer Anavex is pressing ahead with plans to secure approval for its ground-breaking treatment despite a recent setback. 🔗 Full story: buff.ly/fQ90pli #Alzheimers #DrugDevelopment #Biotech #DementiaResearch #RegulatoryNews
What’s the difference between a standard CRO and a strategic partner? It’s all in the dialogue.🗨️ Our Head of Biometrics, Jesse Thissen, sat down with @JCRPharma for a deep dive into building a #biometrics team that drives #drugdevelopment forward👇 youtube.com/watch?v=lnxHRB… #PYC
Today, the International Scietific Advasory Bord gives positive recommendations to out OP JAK project NETPHARM. Thank to all participants and institutions. #CzechScience #DrugDevelopment
In the field of vaccinology, the cold chain is as vital as the formulation itself. Maintaining strict temperature ranges is a technical necessity to ensure vaccine safety and biological efficacy. 🔬 ifgh.org #Vaccinology #VaccineDevelopment #DrugDevelopment
Pharma innovation on the rise 💊 New drug development is accelerating sector growth and shaping the future of healthcare. #Pharma #Healthcare #DrugDevelopment #Biotech #Innovation #ClinicalTrials #Investing #MarketTrends
DON'T MISS OUT! Accelerating Clinical Decisions Through Faster Access to Imaging Data Register now to join us for this free webinar sponsored by Flywheel: hubs.li/Q03V64W_0 #ClinicalTrial #DiagnosticImaging #DrugDevelopment
#ESMOTAT26: In his interview in the #ESMODailyReporter, Timothy A. Yap, TAT Honorary Awardee, shares insights on innovative approaches to exploit synthetic lethality to ‘drug the undruggable’ 📌ow.ly/pUIq50YuA7u #DrugDevelopment
🚨 Voting closes March 31 Help decide the winner of the Medicine Maker Innovation Awards 2025. Cast your vote for the most impactful drug development or manufacturing technology of the year: ow.ly/eVK250YuFa6 #PharmaInnovation #Biopharma #DrugDevelopment
GI toxicity is a major side effect of cancer therapies. Our 3D Colon Organoid Model brings human relevance + high-throughput screening to better predict drug-induced GI toxicity. Explore our poster 👉 shorturl.at/8APaR #Toxicology #Organoids #DrugDevelopment #Innovation
Day one at #BIOEurope – lots of ambition in the room and a real appetite for doing #drugdevelopment smarter. Come find us if you're around to learn more about how we're helping teams make better decisions using #MIDD and biometrics. 🌞
#Drugdevelopment is getting more complex. The decisions teams face are getting harder. We'll be at #BIOEurope next week talking about how modelling and biometrics can help. 🌞 Reach out to book a meeting #PYC @EBDgroup
Which drug development or manufacturing technology deserves the top spot for 2025? Vote in The Medicine Maker Innovation Awards and help choose the winner. Voting closes March 31. 🔗 ow.ly/1xoe50YuEWG #PharmaInnovation #Biopharma #DrugDevelopment
Oral GLP-1s won’t win on convenience. They’ll win on CMC. Small molecule GLP-1 success depends on scalability, safety, and manufacturing economics, not just patient preference 💊🏭 Read more: ow.ly/V9JE50Y5iz3 #GLP1 #CMC #DrugDevelopment
量子コンピューティングとLSTMを、くみあわせてKRASの阻害剤デザインした研究が、in silico medicineのグループからNature Bioにpublish.あのグループつよいなと思いつつ、どこまで量子コンピューティング必要なんだろうか… #創薬 #Drugdevelopment
The December issue is live nature.com/nbt/volumes/43… The cover shows a representation of hybrid quantum computing for drug design. Ghazi Vakili et al. present a hybrid quantum–classical generative model to design molecules to inhibit KRAS activity. Two candidates are synthesized
#NEWS: We are licensing Sitryx’s preclinical program targeting disease‑driving immune pathways - adding a potential first‑in‑class, oral precision therapy approach to our immunology pipeline. Learn more: go.boehringer.com/5GGK #DrugDevelopment #PrecisionMedicine #Immunology
He drives end‑to‑end product development and is passionate about turning innovative science into real therapies. Get to know Preetam here: youtu.be/DT3S5xVc7yg #MeetTheDimeriXperts #Biotech #DrugDevelopment
🧪 Imaging breakthrough lights up drug movement cell by cell, allowing scientists to see exactly which cells medicines bind to. Tested in mice, the method revealed unexpected targets. 🔗 Study: cell.com/cell/fulltext/… #Science #Research #DrugDevelopment
Prof Loong with an engaging talk on patient selection-genomic matching, handling NGS big data, and considering intratumoural heterogeneity - Day 1 @myesmo Advanced Course on #DrugDevelopment in Hong Kong / session chaired by Prof Jayesh Desai & Prof Brigette Ma
米国バイオテクニュースサイトのFierceのもっとも読まれた記事が、レイオフトラッカーと$50M以上資金調達したバイオテクトラッカーって世知辛いな。みんな就活先チェックしてそう。 #創薬 #Drugdevelopment
We’re at #GermanBiotechDays today 👋 Meet the hVIVO team at Booth F09 to discuss smarter, more connected approaches to early development and clinical delivery. 📍 Booth F09 📲 Book via the event partnering app or email [email protected] #Biotech #DrugDevelopment #HVO
Unlock the power of pathology data in precision medicine! Join our free GEN webinar on Dec 4 to see how Proscia Aperture™ transforms clinical insights. Register: hubs.li/Q03SDb0Z0 @Proscia #Pathology #AI #DrugDevelopment
A US$6.92m grant from the Michael J. Fox Foundation will help prepare OPM-201 for clinical studies in people with early Parkinson's disease. 🔗 Full story: buff.ly/osQYMY6 #Parkinsons #ClinicalTrials #DrugDevelopment #NeuroResearch #Biotech
6-Base sequencing: A tool for better drug development ddw-online.com/6-base-sequenc… Follow DDW; Business insights for the global scientific community #DrugDevelopment
On July 15, the ScaDS.AI start-up AI-DT presented its “Co-Scientist”, an AI-supported chatbot for #ProteinDesign and #DrugDevelopment to the #Meetup community.. 🪢 You can find more insights and detailed information in our blog post: scads.ai/meetup-startup…
🎓 Warm congrats to Elvin Maharramov @Ely_win on a successful PhD defense on the principles of designing #antibiotics with limited #resistance. A timely and elegant contribution to the field of #DrugDevelopment on how to design less resistance-prone antibiotics. More info below👇
Something went wrong.
Something went wrong.
United States Trends
- 1. Jokic N/A
- 2. Tony Brothers N/A
- 3. Rudy N/A
- 4. Wolves N/A
- 5. Nuggets N/A
- 6. Knicks N/A
- 7. Brunson N/A
- 8. #WWERaw N/A
- 9. Braun N/A
- 10. Mike Brown N/A
- 11. CJ McCollum N/A
- 12. Donte N/A
- 13. Jaden N/A
- 14. Hawks N/A
- 15. Aaron Gordon N/A
- 16. Speed Racer N/A
- 17. #TexasHockey N/A
- 18. Anthony Edwards N/A
- 19. Adelman N/A
- 20. Mikal Bridges N/A